+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biodesix Inc - Product Pipeline Analysis, 2019 Update

  • ID: 4239708
  • Company Profile
  • 42 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Cardiocom LLC
  • CardioDx Inc
  • Foundation Medicine Inc
  • Roka Bioscience Inc
  • Xagenic Inc
  • MORE
Summary

Biodesix Inc (Biodesix) is a molecular diagnostics company which discovers, develops and commercializes multivariate protein and genomic diagnostic blood tests in oncology for patients and doctors to enable precision medicine. These tests are used for early detection of diseases, diagnosis accuracy, disease monitoring and also provide improved therapeutic guidance for cancer patients. Biodesix’s product portfolio includes GeneStrat, a gene panel of clinically actionable mutations for tumor profiling for patients with advanced lung cancer; and VeriStrat, a serum proteomic test for patients with non-small cell lung cancer. The company collaborates with leading researchers to develop companion diagnostics for use with therapeutic agents and work in partnership with biotechnology and pharmaceutical companies such as Aveo Oncology and Biognosys. Biodesix is headquartered in Boulder, Colorado, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Biodesix Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Cardiocom LLC
  • CardioDx Inc
  • Foundation Medicine Inc
  • Roka Bioscience Inc
  • Xagenic Inc
  • MORE
Biodesix Inc Company Overview
Biodesix Inc Company Snapshot
Biodesix Inc Pipeline Products and Ongoing Clinical Trials Overview
Biodesix Inc – Pipeline Analysis Overview
Biodesix Inc - Key Facts
Biodesix Inc - Major Products and Services
Biodesix Inc Pipeline Products by Development Stage
Biodesix Inc Ongoing Clinical Trials by Trial Status
Biodesix Inc Pipeline Products Overview
BDX-XL2 Test
BDX-XL2 Test Product Overview
BDX-XL2 Test Clinical Trial
Companion Diagnostic Test - NSCLC
Companion Diagnostic Test - NSCLC Product Overview
GeneStrat
GeneStrat Product Overview
HIV Diagnostic Test
HIV Diagnostic Test Product Overview
HRM-MS Based Companion Diagnostic Test
HRM-MS Based Companion Diagnostic Test Product Overview
Multiplexed Proteomic Assay - Alzheimer’s Disease
Multiplexed Proteomic Assay - Alzheimer’s Disease Product Overview
PD-L1 Blood Based Diagnostic Test
PD-L1 Blood Based Diagnostic Test Product Overview
PD-L1 Blood Based Diagnostic Test Clinical Trial
TAm-Seq NGS Lung Cancer Test
TAm-Seq NGS Lung Cancer Test Product Overview
VeriStrat - Breast Cancer
VeriStrat - Breast Cancer Product Overview
VeriStrat - Colorectal Cancer
VeriStrat - Colorectal Cancer Product Overview
VeriStrat - NSCLC
VeriStrat - NSCLC Product Overview
VeriStrat - NSCLC Clinical Trial
Biodesix Inc - Key Competitors
Biodesix Inc - Key Employees
Biodesix Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

Recent Developments
Biodesix Inc, Recent Developments
May 15, 2019: Integrated Diagnostics records strong revenue growth and robust profitability in the first quarter of 2019
Mar 14, 2019: Biodesix VeriStrat data demonstrate independent prediction of immunotherapy outcomes for NSCLC patients
Nov 21, 2018: Integrated Diagnostics Holdings update on 9M2018 results
Nov 12, 2018: Biodesix test predicts response to Atezolizumab in lung cancer
Oct 30, 2018: Biodesix advances ORACLE registry for Lung Nodule Cancer test
Oct 22, 2018: Biodesix Presents Positive Data in Detection of Primary Immunotherapy Resistance to Anti-PD-1 Therapy in Non-Small Cell Lung Cancer
Sep 10, 2018: Biodesix pipeline test demonstrates utility in triaging patients with lung nodules in new CHEST data publication
Aug 29, 2018: Biodesix confirms prognostic value of VeriStrat testing in phase 3 study of patients with advanced lung cancer
Aug 16, 2018: Integrated Diagnostics Holdings results for the six-month period ended 30 June 2018
May 29, 2018: Society for Advanced Bronchoscopy Commits to Enhance Education and Practice Excellence as U S Demand for Bronchoscopy Procedures Increases

Appendix
Methodology
Contact Us
Disclaimer

List of Tables
Biodesix Inc Pipeline Products and Ongoing Clinical Trials Overview
Biodesix Inc Pipeline Products by Equipment Type
Biodesix Inc Pipeline Products by Indication
Biodesix Inc Ongoing Clinical Trials by Trial Status
Biodesix Inc, Key Facts
Biodesix Inc, Major Products and Services
Biodesix Inc Number of Pipeline Products by Development Stage
Biodesix Inc Pipeline Products Summary by Development Stage
Biodesix Inc Ongoing Clinical Trials by Trial Status
Biodesix Inc Ongoing Clinical Trials Summary
BDX-XL2 Test - Product Status
BDX-XL2 Test - Product Description
BDX-XL2 Test - An Observational Registry Study to Evaluate the Performance of the BDX-XL2 Test
Companion Diagnostic Test - NSCLC - Product Status
Companion Diagnostic Test - NSCLC - Product Description
GeneStrat - Product Status
GeneStrat - Product Description
HIV Diagnostic Test - Product Status
HIV Diagnostic Test - Product Description
HRM-MS Based Companion Diagnostic Test - Product Status
HRM-MS Based Companion Diagnostic Test - Product Description
Multiplexed Proteomic Assay - Alzheimer’s Disease - Product Status
Multiplexed Proteomic Assay - Alzheimer’s Disease - Product Description
PD-L1 Blood Based Diagnostic Test - Product Status
PD-L1 Blood Based Diagnostic Test - Product Description
PD-L1 Blood Based Diagnostic Test - Concordance of Immunohistochemistry and a New Blood-based Expression Assay for the Detection of PD-L1 in Patients Diagnosed with Non-small Cell Lung Cancer
TAm-Seq NGS Lung Cancer Test - Product Status
TAm-Seq NGS Lung Cancer Test - Product Description
VeriStrat - Breast Cancer - Product Status
VeriStrat - Breast Cancer - Product Description
VeriStrat - Colorectal Cancer - Product Status
VeriStrat - Colorectal Cancer - Product Description
VeriStrat - NSCLC - Product Status
VeriStrat - NSCLC - Product Description
VeriStrat - NSCLC - An Observational Study Assessing the Clinical Effectiveness of VeriStrat and Validating Immunotherapy Tests in Subjects with Non-small Cell Lung Cancer
Biodesix Inc, Key Employees
Biodesix Inc, Subsidiaries
Glossary

List of Figures
Biodesix Inc Pipeline Products by Equipment Type
Biodesix Inc Pipeline Products by Development Stage
Biodesix Inc Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Roka Bioscience Inc
  • Foundation Medicine Inc
  • Cardiocom LLC
  • CardioDx Inc
  • Xagenic Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4239708
Adroll
adroll